Literature DB >> 33397829

Comparison of Digital PCR and Quantitative PCR with Various SARS-CoV-2 Primer-Probe Sets.

Changwoo Park1,2,3, Jina Lee1,4, Zohaib Ul Hassan1,3,5, Keun Bon Ku3, Seong-Jun Kim3, Hong Gi Kim3, Edmond Changkyun Park3,5,6, Gun-Soo Park3,7, Daeui Park3,8, Seung-Hwa Baek3,8, Dongju Park1,3,9, Jihye Lee10, Sangeun Jeon10, Seungtaek Kim10, Chang-Seop Lee11,12, Hee Min Yoo1,5, Seil Kim1,3,5.   

Abstract

The World Health Organization (WHO) has declared the coronavirus disease 2019 (COVID-19) as an international health emergency. Current diagnostic tests are based on the reverse transcription-quantitative polymerase chain reaction (RT-qPCR) method, which is the gold standard test that involves the amplification of viral RNA. However, the RT-qPCR assay has limitations in terms of sensitivity and quantification. In this study, we tested both qPCR and droplet digital PCR (ddPCR) to detect low amounts of viral RNA. The cycle threshold (CT) of the viral RNA by RT-PCR significantly varied according to the sequences of the primer and probe sets with in vitro transcript (IVT) RNA or viral RNA as templates, whereas the copy number of the viral RNA by ddPCR was effectively quantified with IVT RNA, cultured viral RNA, and RNA from clinical samples. Furthermore, the clinical samples were assayed via both methods, and the sensitivity of the ddPCR was determined to be equal to or more than that of the RT-qPCR. However, the ddPCR assay is more suitable for determining the copy number of reference materials. These findings suggest that the qPCR assay with the ddPCR defined reference materials could be used as a highly sensitive and compatible diagnostic method for viral RNA detection.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; droplet digital PCR (ddPCR); envelope protein gene; nucleocapsid protein gene; reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

Mesh:

Substances:

Year:  2021        PMID: 33397829     DOI: 10.4014/jmb.2009.09006

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  22 in total

1.  Reply to Wang et al., "Assessment of the Abundance and Potential Function of Human Papillomavirus Type 16 Circular E7 RNA".

Authors:  Lulu Yu; Alexei Lobanov; Zhi-Ming Zheng
Journal:  mBio       Date:  2022-05-17       Impact factor: 7.786

2.  SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19.

Authors:  Geidy E Serrano; Jessica E Walker; Cécilia Tremblay; Ignazio S Piras; Matthew J Huentelman; Christine M Belden; Danielle Goldfarb; David Shprecher; Alireza Atri; Charles H Adler; Holly A Shill; Erika Driver-Dunckley; Shyamal H Mehta; Richard Caselli; Bryan K Woodruff; Chadwick F Haarer; Thomas Ruhlen; Maria Torres; Steve Nguyen; Dasan Schmitt; Steven Z Rapscak; Christian Bime; Joseph L Peters; Ellie Alevritis; Richard A Arce; Michael J Glass; Daisy Vargas; Lucia I Sue; Anthony J Intorcia; Courtney M Nelson; Javon Oliver; Aryck Russell; Katsuko E Suszczewicz; Claryssa I Borja; Madison P Cline; Spencer J Hemmingsen; Sanaria Qiji; Holly M Hobgood; Joseph P Mizgerd; Malaya K Sahoo; Haiyu Zhang; Daniel Solis; Thomas J Montine; Gerald J Berry; Eric M Reiman; Katharina Röltgen; Scott D Boyd; Benjamin A Pinsky; James L Zehnder; Pierre Talbot; Marc Desforges; Michael DeTure; Dennis W Dickson; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2022-08-16       Impact factor: 3.148

3.  Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.

Authors:  Nyater Ngouth; Maria Chiara Monaco; Lorenzo Walker; Sydney Corey; Ijeoma Ikpeama; Gary Fahle; Irene Cortese; Sanchita Das; Steven Jacobson
Journal:  Viruses       Date:  2022-06-08       Impact factor: 5.818

Review 4.  Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection.

Authors:  John Charles Rotondo; Fernanda Martini; Martina Maritati; Elisabetta Caselli; Carla Enrica Gallenga; Matteo Guarino; Roberto De Giorgio; Chiara Mazziotta; Maria Letizia Tramarin; Giada Badiale; Mauro Tognon; Carlo Contini
Journal:  Microorganisms       Date:  2022-06-10

Review 5.  Diagnostic, Prognostic, and Therapeutic Value of Droplet Digital PCR (ddPCR) in COVID-19 Patients: A Systematic Review.

Authors:  Angela Ishak; Mousa M AlRawashdeh; Stepan M Esagian; Ilias P Nikas
Journal:  J Clin Med       Date:  2021-12-06       Impact factor: 4.241

Review 6.  Nucleic Acid Testing of SARS-CoV-2.

Authors:  Hee Min Yoo; Il-Hwan Kim; Seil Kim
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

7.  Development of SARS-CoV-2 packaged RNA reference material for nucleic acid testing.

Authors:  Sang-Soo Lee; Seil Kim; Hee Min Yoo; Da-Hye Lee; Young-Kyung Bae
Journal:  Anal Bioanal Chem       Date:  2021-12-27       Impact factor: 4.142

Review 8.  Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic-Experience and Outlines.

Authors:  Monica Neagu; Carolina Constantin; Mihaela Surcel
Journal:  Int J Environ Res Public Health       Date:  2021-12-14       Impact factor: 3.390

9.  The Production of Standardized Samples with Known Concentrations for Severe Acute Respiratory Syndrome Coronavirus 2 RT-qPCR Testing Validation for Developing Countries in the Period of the Pandemic Era.

Authors:  Hoang Quoc Cuong; Nguyen Duc Hai; Hoang Thuy Linh; Nguyen Trung Hieu; Nguyen Hoang Anh; Tran Ton; Tran Cat Dong; Vu Thanh Thao; Do Thi Hong Tuoi; Nguyen Duc Tuan; Huynh Thi Kim Loan; Nguyen Thanh Long; Cao Minh Thang; Nguyen Thi Thanh Thao; Phan Trong Lan
Journal:  Biomed Res Int       Date:  2021-08-03       Impact factor: 3.411

Review 10.  Current diagnostic approaches to detect two important betacoronaviruses: Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Authors:  Zhi Xiong Chong; Winnie Pui Pui Liew; Hui Kian Ong; Chean Yeah Yong; Chong Seng Shit; Wan Yong Ho; Stephanie Y L Ng; Swee Keong Yeap
Journal:  Pathol Res Pract       Date:  2021-07-24       Impact factor: 3.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.